EC Number | Application | Comment | Organism |
---|---|---|---|
3.5.3.15 | drug development | PAD4 is a leading target for the development of a rheumatoid arthritis pharmaceutical | Homo sapiens |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.5.3.15 | 5-aminosalicylic acid | - |
Homo sapiens | |
3.5.3.15 | Azathioprine | - |
Homo sapiens | |
3.5.3.15 | azithromycin | - |
Homo sapiens | |
3.5.3.15 | clindamycin | - |
Homo sapiens | |
3.5.3.15 | leflunomide | - |
Homo sapiens | |
3.5.3.15 | methotrexate | - |
Homo sapiens | |
3.5.3.15 | minocycline | a mixed type inhibitor | Homo sapiens | |
3.5.3.15 | additional information | PAD4 inhibitor screening based on a PAD4-targeted activity-based protein profiling reagent, denoted rhodamine-conjugated F-amidine, RFA, rapid competitive assay method development, overview | Homo sapiens | |
3.5.3.15 | streptomycin | a competitive inhibitor of PAD4 | Homo sapiens | |
3.5.3.15 | sulfamethoxazole | - |
Homo sapiens | |
3.5.3.15 | sulfapyridine | - |
Homo sapiens | |
3.5.3.15 | trimethoprim | - |
Homo sapiens |
EC Number | Metals/Ions | Comment | Organism | Structure |
---|---|---|---|---|
3.5.3.15 | Ca2+ | - |
Homo sapiens |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.5.3.15 | protein-L-arginine + H2O | Homo sapiens | - |
protein-L-citrulline + NH3 | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.5.3.15 | Homo sapiens | - |
- |
- |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.5.3.15 | protein-L-arginine + H2O | - |
Homo sapiens | protein-L-citrulline + NH3 | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.5.3.15 | PAD4 | - |
Homo sapiens |
3.5.3.15 | protein arginine deiminase 4 | - |
Homo sapiens |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
3.5.3.15 | 37 | - |
assay at | Homo sapiens |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
3.5.3.15 | 7.6 | - |
assay at | Homo sapiens |
EC Number | Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|---|
3.5.3.15 | additional information | - |
additional information | inhibition kinetics | Homo sapiens |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
3.5.3.15 | 1.8 | - |
pH 7.6, 37°C, recombinant PAD4 | Homo sapiens | streptomycin | |
3.5.3.15 | 2.4 | - |
pH 7.6, 37°C, recombinant PAD4 | Homo sapiens | leflunomide | |
3.5.3.15 | 5.1 | - |
pH 7.6, 37°C, recombinant PAD4 | Homo sapiens | clindamycin | |
3.5.3.15 | 7.5 | - |
pH 7.6, 37°C, recombinant PAD4 | Homo sapiens | trimethoprim | |
3.5.3.15 | 8.1 | - |
pH 7.6, 37°C, recombinant PAD4 | Homo sapiens | Azathioprine | |
3.5.3.15 | 10 | - |
above, pH 7.6, 37°C, recombinant PAD4 | Homo sapiens | methotrexate | |
3.5.3.15 | 10 | - |
above, pH 7.6, 37°C, recombinant PAD4 | Homo sapiens | 5-aminosalicylic acid | |
3.5.3.15 | 10 | - |
above, pH 7.6, 37°C, recombinant PAD4 | Homo sapiens | sulfamethoxazole | |
3.5.3.15 | 10 | - |
above, pH 7.6, 37°C, recombinant PAD4 | Homo sapiens | sulfapyridine | |
3.5.3.15 | 10 | - |
above, pH 7.6, 37°C, recombinant PAD4 | Homo sapiens | azithromycin |